MINOXIDIL (FOR MEN) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Minoxidil (for Men), and when can generic versions of Minoxidil (for Men) launch?
Minoxidil (for Men) is a drug marketed by P And L, Taro, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb, Copley Pharm, Hikma, L Perrigo Co, Sight Pharms, and Teva. and is included in eleven NDAs.
The generic ingredient in MINOXIDIL (FOR MEN) is minoxidil. There are eight drug master file entries for this compound. Ninety-five suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Minoxidil (for Men)
A generic version of MINOXIDIL (FOR MEN) was approved as minoxidil by WATSON LABS on March 3rd, 1987.
Summary for MINOXIDIL (FOR MEN)
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 11 |
Finished Product Suppliers / Packagers: | 41 |
Raw Ingredient (Bulk) Api Vendors: | 131 |
Clinical Trials: | 57 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MINOXIDIL (FOR MEN) at DailyMed |
Recent Clinical Trials for MINOXIDIL (FOR MEN)
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
BioClever 2005 S.L. | Phase 3 |
Industrial Farmacéutica Cantabria, S.A. | Phase 3 |
Bioskin GmbH | Phase 3 |
Pharmacology for MINOXIDIL (FOR MEN)
Drug Class | Arteriolar Vasodilator |
Physiological Effect | Arteriolar Vasodilation |